Holen Sie sich die Stockscreener-App
1.15
6.48%
0.07
Handel nachbörslich:
1.13
-0.02
-1.74%
Tscan Therapeutics Inc Aktie (TCRX) Neueste Nachrichten
FY2030 Earnings Estimate for TCRX Issued By HC Wainwright - MarketBeat
TScan Therapeutics (NASDAQ:TCRX) Price Target Raised to $5.00 - MarketBeat
Tscan Therapeutics earnings beat by $0.09, revenue topped estimates - Investing.com India
TCRX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
TCRX: Pivotal trial for relapse-preventing T-cell therapy launches in Q2, targeting major market expansion - TradingView
TScan Therapeutics (NASDAQ:TCRX) Releases Quarterly Earnings Results, Beats Estimates By $0.09 EPS - MarketBeat
TScan Therapeutics, Inc. (TCRX) Posts Fourth Quarter Loss, Falls Short of Revenue Expectations - Bitget
TScan Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance
The latest financial data from biotechnology company Tscan Therapeutics, Inc. shows that its current cash and cash equivalents are sufficient to support the company's daily operations and R&D investment through the second half of 2027. - Bitget
TScan Therapeutics 10-K: $10.3M Collaboration Revenue, $(129.8)M Net Loss - TradingView
TScan Therapeutics (NASDAQ: TCRX) advances TSC-101 and reshapes pipeline - Stock Titan
TScan Therapeutics (NASDAQ: TCRX) details 2025 loss, growth and cash runway - Stock Titan
Earnings Breakdown: TScan Therapeutics Q4 - Benzinga
TScan Therapeutics Q4 net loss widens - TradingView
BRIEF-TScan Therapeutics Q4 Net Income USD -22.977 Million - TradingView
TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewswire
TScan Therapeutics completes enrollment in cohort C of Phase 1 Alloha(TM) trial - marketscreener.com
TScan readies pivotal T cell trial and new 2026 studies in hematologic cancers - Stock Titan
TScan Therapeutics Completes Enrollment in Cohort C of Phase 1 ALLOHA™ Trial and Announces FDA Clearance of Investigational New Drug Applications for Heme Candidates TSC-102-A01 and TSC-102-A03 - Sahm
TScan Therapeutics to Participate in the TD Cowen 46th Annual Health Care Conference - The Manila Times
TScan Therapeutics to Present at TD Cowen 46th Annual Health Care Conference on March 4, 2026 - Quiver Quantitative
TScan Therapeutics (TCRX) Projected to Post Quarterly Earnings on Wednesday - Defense World
Is TScan Therapeutics Inc. stock a good dividend stockWeekly Stock Report & Risk Controlled Daily Plans - mfd.ru
TScan Therapeutics (NASDAQ:TCRX) Trading Up 4.6%Here's What Happened - MarketBeat
TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Consensus Recommendation of "Hold" from Brokerages - MarketBeat
Is TScan Therapeutics Inc. stock a value trap2025 Sector Review & Low Drawdown Trading Techniques - mfd.ru
What’s next for TScan Therapeutics Inc. stockQuarterly Market Review & Comprehensive Market Scan Insights - mfd.ru
What are TScan Therapeutics Inc.’s technical support levels2025 Momentum Check & Capital Protection Trade Alerts - mfd.ru
Net income of Tscan Therapeutics from 2020 to 2024 - Statista
Analysis Recap: Will TScan Therapeutics Inc outperform its industry peersJuly 2025 Breakouts & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Aug Highlights: How liquid is BlackRock ESG Capital Allocation Term Trust stock2025 Pullback Review & Risk Adjusted Buy/Sell Alerts - baoquankhu1.vn
Activity Recap: Will TScan Therapeutics Inc outperform its industry peersMarket Trend Summary & Proven Capital Preservation Methods - baoquankhu1.vn
Investor Mood: How does Waterstone Financial Inc perform in inflationary periodsQuarterly Market Summary & Safe Entry Momentum Stock Tips - baoquankhu1.vn
Financial Contrast: Urogen Pharma (NASDAQ:URGN) vs. TScan Therapeutics (NASDAQ:TCRX) - Defense World
Take Profit: Is TScan Therapeutics Inc. forming bullish engulfing patternsWeekly Stock Report & Safe Entry Momentum Tips - mfd.ru
TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Consensus Recommendation of “Hold” from Analysts - Defense World
TScan Therapeutics (NASDAQ:TCRX) Shares Up 1.8%What's Next? - MarketBeat
Jobs Data: How much upside does TScan Therapeutics Inc. haveTrade Entry Report & Real-Time Price Movement Reports - baoquankhu1.vn
Is TScan Therapeutics Inc. stock risky to hold nowMarket Sentiment Report & Daily Entry Point Alerts - bollywoodhelpline.com
Aug Volume: Will TScan Therapeutics Inc stock benefit from M AJuly 2025 Momentum & Verified Stock Trade Ideas - baoquankhu1.vn
Weekly Trades: Will TScan Therapeutics Inc stock benefit from M AMarket Trend Summary & Technical Buy Zone Confirmation - baoquankhu1.vn
TScan Therapeutics Outlines Pivotal 2026 Outlook in Presentation - The Globe and Mail
TScan Therapeutics, Inc. Presents at J.P. Morgan Healthcare Conference - TradingView
Aug Momentum: How does TScan Therapeutics Inc score in quality rankingsEarnings Risk Summary & Real-Time Volume Trigger Notifications - baoquankhu1.vn
Is TScan Therapeutics Inc. stock a safe haven asset2025 AllTime Highs & Fast Gain Swing Alerts - ulpravda.ru
Is TScan Therapeutics Inc. stock dividend yield sustainableJuly 2025 Gainers & AI Driven Stock Movement Reports - ulpravda.ru
Breakout Move: How institutional buying supports TScan Therapeutics Inc stockJuly 2025 Action & Low Volatility Stock Recommendations - Bộ Nội Vụ
Institution Moves: Is TScan Therapeutics Inc. stock safe for conservative investorsOptions Play & Risk Adjusted Swing Trade Ideas - Улправда
Why TScan Therapeutics Inc. stock attracts global investorsRecession Risk & Reliable Breakout Stock Forecasts - Улправда
Is TScan Therapeutics Inc. stock recession proofPortfolio Risk Summary & Reliable Breakout Stock Forecasts - ulpravda.ru
How institutional buying supports TScan Therapeutics Inc. stock2025 Trading Recap & Stepwise Trade Signal Implementation - Улправда
What risks investors should watch in TScan Therapeutics Inc. stock2025 Year in Review & Fast Exit/Entry Strategy Plans - Улправда
Why TScan Therapeutics Inc. stock is a must watch in 2025Weekly Stock Recap & Consistent Profit Trade Alerts - Улправда
Tech Rally: Why TScan Therapeutics Inc stock appeals to analysts2025 Stock Rankings & Proven Capital Preservation Methods - Bộ Nội Vụ
TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
TScan Therapeutics, Inc. (NASDAQ:TCRX) Receives Average Recommendation of “Hold” from Brokerages - Defense World
Guidance Update: Why TScan Therapeutics Inc stock attracts global investorsMarket Growth Review & Verified Swing Trading Watchlist - Bộ Nội Vụ
Weekly Recap: Will West Fraser Timber Co Ltd stock see PE expansionTrade Volume Report & Growth-Oriented Investment Plans - moha.gov.vn
TScan Therapeutics (NASDAQ:TCRX) Major Shareholder Lynx1 Capital Management Lp Acquires 80,069 Shares - MarketBeat
TScan Therapeutics (NASDAQ:TCRX) Major Shareholder Buys 75,500 Shares - MarketBeat
TScan Therapeutics Earnings Notes - Trefis
How TScan Therapeutics Inc. stock reacts to oil pricesTrade Risk Assessment & AI Forecasted Entry/Exit Points - Улправда
3.69%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):